Evaluation of add on efficacy & safety of an ayurvedic formulation in the management of dengue fever & prevention of its complications â?? A double blind clinical study - DF

Central Council for Research in Ayurveda Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1)Fever of >38Deg C of <72 hr duration and at least two of the following criteria indicating probable dengue infection:
•a. Lived or worked in or recent travel to dengue endemic area
•b. Nausea and vomiting
•c. Presence of rash
•d. Aches and pains, including headache, or retro â??orbital, muscle or joint pain
•2) Positive NS1 by ELISA or IgM Dengue

•1.History of presently active intestinal disorders- Bleeding, mal-absorption, history of inflammatory bowel disease
•2.Current usage of drugs â?? anticoagulants, diuretics, steroids, immunosuppressants
•3.Any clinically significant acute illness
•4.Known chronic diseases :- CKD ( GFR <30), CHF, HIV ( CD4 <200) TB in intensive phase of treatment, malignancy, patients on radiotherapy, transplant patients, Nephrotic syndrome,
•5.History of severe drug and /or food allergies
•6.Exposure to investigational agent within 30 day prior to study drug administration
•7.Clinically significant abnormal physical exam unrelated to dengue fever
•8.Pregnancy & lactation

发起方

Central Council for Research in Ayurveda Sciences